← Back to headlines
Bank of America Raises McKesson Target on Biosimilar Push
Bank of America has raised its price target for McKesson (MCK) to $1,040, seeing upside potential from the company's biosimilar initiatives.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Aon Agrees to $17 Billion Acquisition of Rival USI Insurance
32m ago
Glacier Bancorp Appoints Byron Pollan as New Chief Financial Officer
40m ago
Prediction Platform Kalshi Bans Former Congressman George Santos for Life
57m ago
U.S. Treasury Yields Surge as Fed Official Signals Support for Rate Hike
1h ago